Alexa
  • Directory of Taiwan

FDA head: Baby formula factory could reopen by next week

WASHINGTON (AP) — The head of the Food and Drug Administration told lawmakers Thursday that a shuttered baby formula factory could be up and running as soon as next week, though he sidestepped questio...

EXPLAINER: What's behind the baby formula shortage?

WASHINGTON (AP) — Many parents are hunting for infant formula because of a combination of short- and long-term problems that has hit most of the biggest U.S. brands. Millions of babi...

Rare cases of COVID returning pose questions for Pfizer pill

WASHINGTON (AP) — As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking t...

Lawmakers scrutinize McKinsey's opioid, FDA consulting work

WASHINGTON (AP) — House Democrats vowed to continue investigating consulting giant McKinsey's work with opioid drugmakers after a Wednesday hearing detailed how the firm had advised companies pushing ...

Plan to ban menthol cigarettes prompts late lobbying blitz

WASHINGTON (AP) — As federal officials finalize a long-awaited plan to ban menthol cigarettes, dozens of interest groups have met with White House staffers to try to influence the process, which has t...

E-cigs using synthetic nicotine come under FDA oversight

WASHINGTON (AP) — U.S. regulators will soon begin cracking down on vaping companies using a now-closed loophole, including a line of fruit-flavored e-cigarettes that have become teenagers' top choice....

US experts wrestle with how to update COVID-19 vaccines

WASHINGTON (AP) — More than two years into the COVID-19 pandemic, U.S. health officials are beginning to grapple with how to keep the vaccines updated to best protect Americans from the ever-changing ...

US pulls GSK's COVID drug as omicron sibling dominates cases

WASHINGTON (AP) — GlaxoSmithKline’s IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most U.S. cases, federal health ...

FDA panel narrowly sides against experimental ALS drug

WASHINGTON (AP) — Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig’s disease, a potential setback for patient groups wh...

FDA skeptical of benefits from experimental ALS drug

WASHINGTON (AP) — Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying ...

Pressured by patients, FDA reviews ALS drug with modest data

WASHINGTON (AP) — When patients are battling a terminal illness and want access to an experimental drug, how much evidence that it works should regulators require before approval? Th...

FDA details problems at plant behind recalled baby formula

WASHINGTON (AP) — Baby formula maker Abbott failed to maintain sanitary conditions and procedures at the Michigan manufacturing plant recently linked to a cluster of infant illnesses, according to fin...

FDA: Do not use recalled infant formulas tied to infections

WASHINGTON (AP) — U.S. health officials warned parents on Thursday not to use three popular powdered infant formulas manufactured at an Abbott plant in Michigan that investigators recently linked to b...

Altria says judge has dismissed lawsuit over Juul investment

WASHINGTON (AP) — Tobacco giant Altria said Tuesday that an administrative law judge has dismissed a federal lawsuit alleging the company's partnership with e-cigarette maker Juul Labs amounted to an ...

Insider Q&A: NIH official on testing for infectiousness

WASHINGTON (AP) — More than two years into the COVID-19 pandemic the U.S. is still grappling with its coronavirus tests: how to improve them and how to make more of them. Dr. Bruce T...